Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression.
Hilvo M, Denkert C, Lehtinen L, Müller B, Brockmöller S, Seppänen-Laakso T, Budczies J, Bucher E, Yetukuri L, Castillo S, Berg E, Nygren H, Sysi-Aho M, Griffin JL, Fiehn O, Loibl S, Richter-Ehrenstein C, Radke C, Hyötyläinen T, Kallioniemi O, Iljin K, Oresic M. Hilvo M, et al. Among authors: richter ehrenstein c. Cancer Res. 2011 May 1;71(9):3236-45. doi: 10.1158/0008-5472.CAN-10-3894. Epub 2011 Mar 17. Cancer Res. 2011. PMID: 21415164
Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism.
Budczies J, Brockmöller SF, Müller BM, Barupal DK, Richter-Ehrenstein C, Kleine-Tebbe A, Griffin JL, Orešič M, Dietel M, Denkert C, Fiehn O. Budczies J, et al. Among authors: richter ehrenstein c. J Proteomics. 2013 Dec 6;94:279-88. doi: 10.1016/j.jprot.2013.10.002. Epub 2013 Oct 11. J Proteomics. 2013. PMID: 24125731 Clinical Trial.
Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study.
Budczies J, Denkert C, Müller BM, Brockmöller SF, Klauschen F, Györffy B, Dietel M, Richter-Ehrenstein C, Marten U, Salek RM, Griffin JL, Hilvo M, Orešič M, Wohlgemuth G, Fiehn O. Budczies J, et al. Among authors: richter ehrenstein c. BMC Genomics. 2012 Jul 23;13:334. doi: 10.1186/1471-2164-13-334. BMC Genomics. 2012. PMID: 22823888 Free PMC article.
The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions.
Müller BM, Keil E, Lehmann A, Winzer KJ, Richter-Ehrenstein C, Prinzler J, Bangemann N, Reles A, Stadie S, Schoenegg W, Eucker J, Schmidt M, Lippek F, Jöhrens K, Pahl S, Sinn BV, Budczies J, Dietel M, Denkert C. Müller BM, et al. Among authors: richter ehrenstein c. PLoS One. 2013 Jun 27;8(6):e68252. doi: 10.1371/journal.pone.0068252. Print 2013. PLoS One. 2013. PMID: 23826382 Free PMC article.
Solid neuroendocrine carcinomas of the breast: metastases or primary tumors?
Richter-Ehrenstein C, Arndt J, Buckendahl AC, Eucker J, Weichert W, Kasajima A, Schneider A, Noske A. Richter-Ehrenstein C, et al. Breast Cancer Res Treat. 2010 Nov;124(2):413-7. doi: 10.1007/s10549-010-1178-3. Epub 2010 Sep 25. Breast Cancer Res Treat. 2010. PMID: 20872069
Endothelial progenitor cells in breast cancer patients.
Richter-Ehrenstein C, Rentzsch J, Runkel S, Schneider A, Schönfelder G. Richter-Ehrenstein C, et al. Breast Cancer Res Treat. 2007 Dec;106(3):343-9. doi: 10.1007/s10549-007-9505-z. Epub 2007 Feb 15. Breast Cancer Res Treat. 2007. PMID: 17972175
15 results